Aerie Pharmaceuticals reported $228.19M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Alimera Sciences ALIM:US $ 43.13M 0.23M
Amarin AMRN:US $ 0M 0M
Bluebird Bio BLUE:US $ 0M 0M
Coherus Biosciences CHRS:US $ 407.17M 1.09M
Endo International Ordinary Shares ENDP:US $ 8300.6M 3.52M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2573.86M 2.58M
Insmed INSM:US $ 572.61M 8.59M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 34243M 1526M
Pacira Pharmaceuticals PCRX:US $ 481.9M 6.51M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M
Valeant Pharmaceuticals VRX:CN $ 22358M 1081M
Zoetis ZTS:US $ 6592M 604M
Zogenix ZGNX:US $ 155.87M 2.24M